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Background. Hypergammaglobulinemia and polyclonal B-cell activation commonly occur in Plasmodium sp. infections. Some
of the antibodies produced recognize self-components and are correlated with disease severity in P. falciparum malaria.
However, it is not known whether some self-reactive antibodies produced during P. falciparum infection contribute to the
events leading to cerebral malaria (CM). We show here a correlation between self-antibody responses to a human brain protein
and high levels of circulating TNF alpha (TNFa), with the manifestation of CM in Gabonese children. Methodology. To study
the role of self-reactive antibodies associated to the development of P. falciparum cerebral malaria, we used a combination of
quantitative immunoblotting and multivariate analysis to analyse correlation between the reactivity of circulating IgG with
a human brain protein extract and TNFa concentrations in cohorts of uninfected controls (UI) and P. falciparum-infected
Gabonese children developing uncomplicated malaria (UM), severe non-cerebral malaria (SNCM), or CM. Results/Conclusion.
The repertoire of brain antigens recognized by plasma IgGs was more diverse in infected than in UI individuals. Anti-brain
reactivity was significantly higher in the CM group than in the UM and SNCM groups. IgG self-reactivity to brain antigens was
also correlated with plasma IgG levels and age. We found that 90% of CM patients displayed reactivity to a high-molecular
mass band containing the spectrin non-erythroid alpha chain. Reactivity with this band was correlated with high TNFa
concentrations in CM patients. These results strongly suggest that an antibody response to brain antigens induced by P.
falciparum infection may be associated with pathogenic mechanisms in patients developing CM.
Citation: Guiyedi V, Chanseaud Y, Fesel C, Snounou G, Rousselle J-C, et al (2007) Self-Reactivities to the Non-Erythroid Alpha Spectrin Correlate with
Cerebral Malaria in Gabonese Children. PLoS ONE 2(4): e389. doi:10.1371/journal.pone.0000389
INTRODUCTION
Malaria remains one of the leading causes of death in most of sub-
Saharan Africa, and mortality rates are particularly high for
children under the age of five years, pregnant women and non-
immune individuals [1]. Fatal outcome occurs nearly exclusively in
patients infected with Plasmodium falciparum who progress to severe
malaria [1,2]. Severe anemia and cerebral malaria (CM) are the
most prevalent types of severe P. falciparum malaria, and CM
displays the more acute clinical spectrum. In CM, the sequestra-
tion of mature P. falciparum-infected red blood cells to the cerebral
endothelium is clearly a central event in the pathogenesis.
However, the sequences of pathological events leading to fatal
malaria in humans remain poorly characterized. Gaining an
understanding of the mechanisms involved in CM will be crucial
to the development of new preventive or curative therapies and/or
vaccines, as well as to defining prognostic markers.
It has been recently shown that production of autoantibodies to
brain voltage-gated calcium channels, but not other calcium
channels, increased with severity of P. falciparum infection in
Kenyan children [3]. Antibodies to central nervous system
proteins have been associated with seizure and epilepsies in
several autoimmune diseases and are thought to play a role in the
pathology [4]. Hypergammaglobulinemia and polyclonal B-cell
activation commonly occur in Plasmodium sp. Infections [5]. Some
of the antibodies produced recognize self-components from
various tissues and organs, such as erythrocytes, lymphocytes,
nucleic acid structures, cytoskeleton, smooth muscle, heart and
thyroid [6,7–10]. Antibodies against phospholipid (PL), cardiolipin
(CL), ssDNA, dsDNA, and rheumatoid factor are correlated with
disease severity in P. falciparum-infected patients [6,9,11–13], and
Coombs’ anti-globulin test is positive in P. falciparum-infected
individuals suffering from severe anemia [14,15]. It is unclear
whether self-reactive antibodies play a role in protective immunity
against blood-stage parasites [16]. Moreover, it is not known
whether the presence of these autoantibodies is a consequence of
the infection or whether it contributes to the events leading to
severe and particularly to P. falciparum cerebral malaria.
Another factor thought to influence clinical outcome of malaria
is the fine balance between the pro- and anti-inflammatory
cytokines, such as TNFa, IFNc and IL-10 produced during the
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infection, that modulate parasite–induced immune responses
[17,18]. In particular, tumor necrosis factor a (TNFa) is thought
to play an important role in CM physiopathology by inducing
changes in cerebral endothelial cells leading to the surface
expression of adhesion molecules thereby enhancing parasitized
erythrocyte sequestration [17,18]. The adhesion of parasitized red
blood cells to the brain vascular endothelium is considered to lead
to a decrease in cerebral blood flow and to contribute to the
induction of brain damage and coma [17,19–22]. Anti-inflamma-
tory cytokines, such as IL-10, contribute also to the regulation of
the inflammatory response during malaria [18]. Thus, the
outcome of P. falciparum infection may depend on a fine balance
between appropriate and inappropriate induction of theses
immune regulatory factors.
Whether IFNc, TNFa and IL-10 regulate the self-reactive
antibody response during malaria, as is the case for primary biliary
cirrhosis, remains to be shown [23].
We wished to investigate a) whether autoantibodies directed
against brain tissues occur in P. falciparum malaria, and if so to
identify the host molecules recognised, b) if there is a relationship
between autoantibody levels and clinical symptoms, and c) whether
self-reactive antibodies, in association with a defined pattern of
circulating cytokines, are associated to the development of CM. We
therefore recruited three groups of patients developing uncompli-
cated (UM), severe non-cerebral (SNCM) or cerebral malaria
attending the Owendo Pediatric Hospital and Libreville Hospital
Center in Gabon. We further investigated whether levels of
circulating IFNc, TNFa and IL-10 in these groups of patients were
associated with the level of IgG self-reactivitive antibodies response.
METHODS
Patients and Methods
Study population Patients were included in the study only after
informed consent had been obtained from their parents, after
admission at the Owendo Pediatric Hospital (OPH) and Libreville
Hospital Center (LHC) in Gabon, between 1996 and 1999. The
ethics committee of the Gabon Health Office approved this study.
Patients were assigned to the various groups on the basis of World
Health Organization guidelines for the definition of uncompli-
cated and severe malaria. The children included in this study were
aged between 2 months and 5 years, and fell into three groups for
P. falciparum malaria: 1) uncomplicated malaria (UM), 2) severe
non-cerebral malaria (SNCM) with severe anemia (hemoglobin
level , 5 g/dl) or hypoglycemia (glycemia,2.2 mmol/ml), and 3)
cerebral malaria (CM) with a Blantyre Coma Score inferior or
equal to 2, or three convulsive episodes during the 24 hours before
admission, with a post-critical comatose stated lasting.15 minutes.
We also studied two control groups—the uninfected group (UI)—
comprising healthy children with P. falciparum-negative thin blood
smears, and European uninfected group (EUIC), who had never
been exposed to malaria. All patients presenting diseases other
than malaria were excluded from the study. All the UI subjects (18)
were from the same area of Libreville City, and the patients in the
UM (57), SNCM (24) and CM (14) groups were all recruited from
the OPH and LHC hospitals. During the recruitment period, 7%
(8/113) of the patients died in CM group. There was no significant
difference in mean age and in sex ratio between the children in the
various groups.
Patients were treated with amodiaquine or quinine, depending on
disease severity. Children with uncomplicated malaria were given
oral amodiaquine (25 mg/kg) for three days; those with severe
malaria received intravenous quinine (25 mg/kg/day) for five days.
Children with severe anemia underwent blood transfusion.
Blood sample collection and parasite assessment Venous
blood from each patient was collected into EDTA in sterile
vacutainers on the day of hospitalization (day-0, before any
treatment), at day-7 and day-30. Plasma was obtained by
centrifuging blood samples at 5000 g for 15 min, and stored at
280uC until use. Parasitemia was assessed by counting asexual forms
of P. falciparum on thin blood smears under a light microscope after
staining with 10% Giemsa solution. Parasitemia is expressed as the
percentage of infected red blood cells.
Quantification of total plasma IgG and cytokines Plasma
total IgG of the patients were quantified by ‘‘Sandwich type
ELISA’’ method as described in detail elsewhere [24,25]. A
sandwich-type ELISA was used to determine IFNc, TNFa and IL-
10 levels, using a kit (OptEIA set, Pharmingen, BD Bioscience,
France), according to the manufacturer’s recommendations.
Brain extract preparation, gel electrophoresis and
immunoblotting Patterns of recognition of brain proteins by
plasma IgG were detected by quantitative immunoblotting
(PANAMA-blot method), using a protein extract from the brain
of a healthy individual as the source of antigens as previously
described [26,27]. Briefly, normal human brain protein extracts
(about 300 mg protein/gel) were separated by a standard SDS-
PAGE in a 10% polyacrylamide gel. The proteins were transferred
onto nitrocellulose membranes (Schleicher&Schuell, Dassel,
Germany) by semi-dry electrotransfer (Pasteur Institute, Paris,
France). Membranes were then incubated with patient plasma
samples diluted 1:20 in PBST (non-adjusted assay), or to a total
IgG concentration of 200 mg/ml (adjusted assay), in a Cassette
Miniblot System (Immunetics, Cambridge, MA, USA). The
immunoglobulin reactivities were detected by incubation with
chain-specific secondary rabbit anti-human IgG coupled to
alkaline phosphatase (Sigma-Aldrich, Saint Quentin Fallavier,
France). Dried membranes were scanned with a high resolution
scanner (600 DPI). We used a mixture of diverse Gabonese plasma
preparations diluted 1/20 as the standard plasma sample.
Protein identification by mass spectrometry Protein
bands of interest were localised following migration on 10%
acrylamide gels and staining with Coomassie blue. The proteins
present in these bands were identified by peptide mass
fingerprinting with a matrix-assisted laser desorption ionization-
time of flight (MALDI-TOF) mass spectrometer (MS), Voyager
DE-STR (Applied Biosystems, Framingham, MA, USA) [28].
Statistical analysis Immunoblot data were analyzed by multi-
variate statistical methods, using IGOR software (Wavemetrics, Lake
Oswego, OR), including specially written software packages. The
standard migration scale was divided into sections around individual
peaks of immunoreactivity. Section-wise absorbance values were
subjected to principal component analysis (PCA), based on covari-
ance calculation. For quantitative comparisons between groups, we
used either Mann-Whitney (between two groups) or Kruskal-Wallis
tests (.2 groups). Qualitative association was tested by Pearson’sx2
test. The association between continuous quantitative parameters
was assessed by linear regression, with the exception of correlations
between two different types of parameters such as reactivity and
cytokine profiles, which were tested by Spearman’s rank correlation.
P values,0.05 were considered significant.
RESULTS
Diversity of IgG reactivity with brain antigens in the
various clinical groups
We carried out an adjusted assay, in which patient plasma was
systematically diluted to an identical total IgG concentration
(200 mg/ml) before testing, so as to determine the proportion of
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total IgG accounted for autoantibodies. Figure 1 shows typical
examples of the immune profiles obtained with the brain extract, for
several patients of each group, on days 0, 7 and 30. Reactivity
patterns were more diverse in the UM, SNCM and CM groups than
they were in the UI and EUIC (European uninfected controls)
group, but these did not change with the time of collection (figure 1a).
The median number of cerebral antigens recognized by plasma IgG
was significantly higher in UM (p=0.02), SNCM (p=0.01) and CM
(p=0.02) than in UI subjects, whereas the difference in the number
of bands recognized did not differ significantly between UM, SNCM
and CMpatients (data not shown). We determined the proportion of
patients in each group with plasma IgG recognizing a particular
number of bands (figure 1b). The proportion of individuals with
a large number of bands (.12) was higher in CM (71%) and SNCM
(58%) than in UM (49%) and UI (17%) subjects. The overall
difference between groups was significant (x2= 11.2, p= 0.01). Thus,
the number of brain antigens recognized by circulating IgG from P.
falciparum-infected individuals increased with disease severity, with
the sera of most UI subjects reacting with less than eight bands
(figure 1b).
Relationship between the size of the IgG repertoire
directed against brain antigens and disease severity
We investigated the distribution of circulating IgG reactivities to
brain proteins by carrying out a second quantitative immunoblot
assay, using the same method as above but analyzing every plasma
sample at a fixed dilution of 1/20 (non–adjusted assay). In this
assay, we included 10 European children of similar ages who had
never been exposed to malaria. We then analyzed the patterns of
reactivity of the patients by principal component analysis (PCA),
fitted to the Gabonese data. In PCA, the components are
identified in decreasing order of importance. Thus, by definition,
the first two components identified account for a large proportion
of total reactivity. Factor 1 was characterized by overall positive
factor loads (figure 2a). Factor 1 scores, therefore, provide
a quantitative measure of total reactivity. Factor 2 scores mostly
reflected the recognition of one particular section (the section-0,
including the band-0) rather than the others (figure 2b, figure 2c).
Factor 1 and factor 2 scores were higher in CM than in UI, UM
and SNCM patients (figure 3a and 3b). Factor 1 scores were
significantly lower in EUIC than in Gabonese UI (p= 0.045). No
significant difference was observed between the UI, UM, SNCM
and CM groups (figure 3a). Factor 2 scores differed significantly
between CM and SNCM patients (p = 0.001) and between CM
and UM patients (p = 0.04) (figure 3b).
The proportion of patients with high factor 1 scores (and
therefore high overall anti-brain reactivity) appeared to be highest
for CM patients, but no significant difference was found between
the groups (figure 3c). The proportion of patients with high factor
2 scores was significantly lower in EUIC, UI, UM and SNCM
(70%, 67%, 61%, and 50%, respectively) than in CM (100%)
subjects (x2All Groups = 10.4, p = 0.03) (figure 3d). Remarkably, all
CM patients had factor 2 scores above the mean.
In addition to the day 0 samples, we also analyzed samples
taken from the same individuals (14 UI, 42 UM, 27 SNCM and 3
CM patients) on days 7 and 30 after admission. The factor scores
obtained for these samples were determined by projection, using
factor loads calculated from day 0 data. Factor 1 scores increased
significantly between days 0 and 7 in patients developing malaria
whereas, on day 30, reactivity patterns were identical to those on
day 7 for most of the children (data not shown). No such increase
was observed in factor 2 scores.
Reactivity to brain proteins according to age, sex,
parasitemia and circulating IgG levels
The reactivity to brain antigens represented by factor 1 scores was
significantly correlated with age (R=+0.39, p=0.001) in the non-
adjusted assay, whereas no correlation was found between reactivity
profiles, sex and parasitemia (data not shown). However, circulating
IgG concentration was found to be significantly correlated with
reactivity in all groups (R=+0.21, p=0.03) except for uninfected
controls (data not shown). These correlations with age and total IgG
were less significant (p=0.03 and 0.04, respectively) for PCA
calculated from the adjusted assay, previously used for the
assessment of diversity, which may therefore better reflect intrinsic
repertoire properties. Here, high factor 1 scores were observed only
for patients with low total IgG concentrations (Figure 4a). We
assigned the children to three subgroups, as follows: a) low anti-brain
reactivity and moderate levels of circulating IgG (below 25 mg/ml,
corresponding to twice normal IgG concentration in children), b)
high anti-brain reactivity and moderate levels of circulating IgG and
Figure 1. IgG immunoreactivity profiles from malaria patients. A.
Example of reactivities of IgG from patients sera in the EUIC (3), UI (2),
UM (2), SNCM (2) and CM (3) groups, respectively at day 0, day 7 and/or
day 30 for each patient. B. Frequency of patients in each group
recognizing ranges of 0–4, 5–8, 9–12 and more than 12 bands,
respectively. 1: UI, 2: UM, 3: SNCM, 4: CM.
doi:10.1371/journal.pone.0000389.g001
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d) low anti-brain reactivity and high levels of circulating IgG.
Subgroups a and b displayed unequal distributions of UM, SNCM
and CM patients. UM and SNCM patients were overrepresented in
subgroup a (72% of the UM and 75% of the SNCM patients, but
only 36% of the CM patients; x-squared test for all groups:
p= 0.049). Subgroup b included 50% of the CM patients but only
21% of all samples (x-squared test: p= 0.028), while there was no
preferential distribution in subgroup d.
During the first twelve months of life, the plasma may contain
maternal IgG. The differences between the three subgroups were
indeed more pronounced when considering only children over the
age of one year: subgroup a contained 89% of the UM and 79% of
the SNCM patients but only 11% of the CM patients, whereas
78% of CM patients were found in subgroup b (figure 4b), and the
association with clinical status was highly significant for both
(p = 0.0005 and 0.0004, respectively). CM patients over the age of
one year also showed the highest factor 1 scores (Figure 4c), being
significantly higher than for SNCM and UM patients (p = 0.005
and 0.009, respectively). These results, where the effect of both age
and total IgG concentrations was largely eliminated by the
adjusted assay, indicate a specific self-reactive antibody repertoire
induced during P. falciparum infection.
Figure 2. PCA factor loads. Relative contributions of reactivity bands to the first two PCA factors calculated on unadjusted profiles of IgG
immunoreactivity to brain proteins separated by 10% SDS-PAGE. A. PCA factor 1. B. PCA factor 2. C. localisation of the band-0 on Western blot profile
obtain after the computer analysis of membrane Nu5. Bands are ordered from high to low molecular weight (between about 230 kDa and 20 kDa).
doi:10.1371/journal.pone.0000389.g002
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IgG reactivity to a high-molecular weight brain
antigen is associated with CM
Profiles of the reactivity of standard and patient plasma samples
with brain proteins were separated into 33 sections on the
standardized migration scale. PCA analysis revealed that reactivity
with section 0 (band-0), corresponding to a set of high-molecular
weight proteins, was the most informative (figure 2). In the two
types of assay, this section had the most impact on PCA factor 1.
For PCA factor 2, section 0 was distinguished from the rest of the
repertoire by a positive load. At least three proteins with estimated
molecular weights of 230 kDa, 189 kDa and a double band at
147 kDa on SDS-PAGE were detected in this region in a 6%
acrylamide gel with protein size standards (figure 2c, figure 5). In
adjusted assays, plasma IgG from children with CM over the age
of one year reacted more strongly with band-0 than did plasma
IgG from children of the UM and SNCM groups (both p= 0.0008)
(figure 6): 90% of the CM patients had a detectable reaction,
versus 50% SNCM 44% UI and 39% UM patients (data not
shown). The results obtained in unadjusted assays were qualita-
tively similar, but the differences between CM and UM and
between CM and SNCM were less significant (p = 0.02 and 0.01,
respectively). Unadjusted reactivity with band-0 proteins increased
with age (R= 0.25; p = 0.04) (Data not shown).
Mass spectrometry identification
Proteins from human brain extract were separated on a 10%
acrylamide gel. After Coomassie staining, three bands correspond-
ing to reactive bands detected by Western blot were cut and their
protein contents analyzed by peptide mass fingerprinting. In three
independent experiments, band 1 corresponded to the beta chain
of the non-erythroid spectrin isoform 2 while bands 2 and 3 to
seven different isoforms of the alpha chain of the non-erythroid
spectrin. In this latter case, it was not possible to distinguish if only
one, several or all these isoforms were present in bands 2 and 3
(Figure 5).
Figure 3. PCA factor scores from unadjusted IgG immunoreactivity profiles. A. Groupwise distribution of factor 1 scores. B. Groupwise distribution
of factor 2 scores. C. Frequency of patients in each group with above-average factor 1 scores. D. Frequency of patients in each group with above-
average factor 2 scores.
doi:10.1371/journal.pone.0000389.g003
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Relationships between IgG reactivity to brain
proteins, plasma cytokines concentrations and
clinical manifestations of malaria
Plasma IL-10 concentrations were significantly lower in the UI
group than in the UM (p= 0.002) and severe malaria groups
(p,0.0001), but were similar in the UM, SNCM and CM groups
(data not shown). IFNc concentrations were highest in the UM
and CM groups (data not shown). The differences between the
CM and UI groups were statistically significant (p = 0.007),
whereas no significant differences were observed between the
UM, SNCM and CM groups. Plasma TNFa concentrations were
significantly higher in the SNCM and CM groups than in the UM
group (p = 0.0001 and p= 0.001, respectively). In addition, 75% of
CM patients who died had a very high plasma level of TNFa
(62.5% from 500 to 1520 pg/ml, and 12.5% from 100 to 500 pg/
ml) (data not shown).
We assessed whether IgG autoantibody response and the type of
disease were associated with cytokines concentrations in P.
falciparum-infected patients. Plasma IFNc and IL-10 concentrations
were not associated with reactivity in the various groups. In the
adjusted assay, reactivity to brain antigens, as measured by PCA
factor 1 score, was positively correlated with TNFa concentration.
This correlation was significant for children over the age of one
year (RSpearman = +0.41, p = 0.02) (figure 7a). Factor 1 score was
particularly high in the CM patients with the highest plasma
TNFa concentrations (.100 pg/ml). The intensity of the un-
adjusted (but not of the adjusted) reactivity with band-0 was also
correlated with TNFa concentrations (in all children: RSpear-
man =+0.35, p = 0.008; children aged over 1 year: RSpear-
man =+0.54, p= 0.002) (Figure 7b). Reactivity with band-0 was
significantly stronger for the CM patients with the highest plasma
TNFa concentrations (.100 pg/ml) than for SNCM and UM
patients (p = 0.0006 and p= 0.003, respectively) (figure 7c).
DISCUSSION
In humans, detailed analyses of the events leading to CM and
mortality from CM are restricted by ethical and practical
considerations. First, sample collection is limited to peripheral
blood, and post-mortem sampling is often unacceptable on
cultural and religious grounds. Second, only a small proportion
(ca. 1%) of the patients admitted with P. falciparum infection
actually develops CM. Thus, it is difficult to recruit cohorts with
sufficient numbers of patients meeting the CM case definition.
Finally, the immuno-parasitological history of patients recruited in
zones of moderate to high endemicity is generally difficult to
establish, and thus the CM patients investigated might not be
strictly homogeneous. Nonetheless, comparison of different
cohorts with defined disease phenotypes has proven to be valuable
in identifying factors specifically related to a particular pathology.
In contrast to previous studies analysing the immunoglobulin
reactivity against one single antigen during malaria, in the current
Figure 4. Properties of adjusted IgG anti-brain reactivity in terms of
PCA factor 1 scores. A. Relationship to total plasma IgG concentration,
and dissection into three subgroups : a (IgG,25 mg/ml; F1,0.5),
b (IgG,25 mg/ml; F1.0.5), d (IgG.25 mg/ml; F1,0.5). B. Frequencies
of patients above one year of age in each group, over the three
subgroups. C. Groupwise distribution of PCA factor-1 scores among
patients older than one year, with horizontal bars indicating median
values. The significance of the difference between patients with CM and
with non cerebral clinical malaria (UM+SNCM) is indicated.
doi:10.1371/journal.pone.0000389.g004
Figure 5. Mass fingerprinting. Proteins from human brain extract were
separated on a 10% acrylamide gel. After Coomassie staining, three
bands corresponding to reactive bands detected by Western blot were
cut and their protein contents analyzed by peptide mass fingerprinting
as described in the material and methods section. Three independent
experiments were carried out and conducted to identical protein
identifications. Results in figure 5 correspond to those obtain in one
typical experiment.
doi:10.1371/journal.pone.0000389.g005
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report we used a more global approach to analyze the response to
P. falciparum infection without apriori forming a hypothesis about
the nature of the response. In this perspective, the PANAMA-blot
method coupled to computer-assisted analysis was used to
investigate the global repertoire of auto-antibodies reacting to
brain proteins, the organ central to CM pathology. Using this
strategy associating large scale antigen-antibody reactivities and
multivariate statistical analyses, we assessed the relationship
between self-reactive antibodies and CM pathogenesis.
Our data showed high self-reactivity levels of IgG to brain
antigens in the serum of P. falciparum-infected patients but not in
UI or in EUIC controls. The size of the repertoire, in terms of the
brain antigen diversity recognized by circulating IgG, increased
significantly with disease severity. In addition, self-reactive serum
IgG from 90% of CM patients displayed strong reactivity with the
brain proteins found in band-0 of the Panama Blot. All the
proteins in this region were demonstrated by MALDI-TOF
analysis to be derived from the non-erythroid spectrin a and
b chains, the a chain being more abundant. Non-erythroid
spectrin is a major component of the cortical cytoskeleton of most
eukaryotic cells. It forms heterodimers composed of a and
b subunits [29]. The a chain of the non-erythroid spectrin (a-II
spectrin) is a candidate autoantigen in primary Sjo¨gren’s syndrome
[30]. This protein is cleaved during apoptosis [31,32], and
cleavage is effected following activation of a neutral calcium
activated protease, calpain [32]. Interestingly, it has been recently
shown that neuronal calpain is activated in P. berghei ANKA
infected mice developing CM [33]. In addition, it is also known
that inappropriate upregulation of calpain could also contribute to
increased neurodegeneration in autoimmune encephalomyelitis
and induced apoptosis of neuronal cells following cerebral hypoxia
and ischemia [34–36].
We also observed that serum TNFa concentrations were
correlated with brain antigen self-reactive antibodies (band-
0 proteins). These concentrations were clearly higher in patients
presenting severe malaria than in those admitted with un-
complicated malaria. Furthermore, the CM patients with the
highest TNFa plasma concentrations (.100 pg/ml) also presented
the highest levels of anti-brain reactivity. TNFa has been
associated with pathogenic processes leading to CM [17]. Fever
and other clinical and biological manifestations of malaria such as
hypoglycemia, anemia and the adhesion of mature blood stage
parasites to the brain vascular endothelium that probably
decreases cerebral blood flow, leading to brain damage and coma,
have been directly related to the secretion of this cytokine [18,37].
In our study, 62.5% (5/8) of patients who died from cerebral
malaria presented simultaneously high TNFa concentrations and
high anti-brain reactivity levels. Thus, our data support the notion
that the antibody-mediated self-reactive pathway is associated with
the inflammatory process linked to CM development and would
suggest that both high TNFa concentrations and high self-reactive
response to brain a spectrin could be co-factors implicated in the
disease severity.
The presence of self-reactive antibodies against non-cerebral
antigens associated to malaria severity had been reported previously
[6,9,11–13]. However, to our knowledge, the present study is the first
where the whole spectrum of brain antigens, rather than a specific
candidate protein, were analysed with respect to IgG autoantibodies
present in the sera of a panel of patient groups representative of
distinct clinical malaria phenotypes.
Figure 6. Intensity of IgG reacting to band-0 in children older than one year in each group. Horizontal bars indicate medians; the significant
difference between patients with cerebral malaria (CM) and with UM+SNCM is indicated.
doi:10.1371/journal.pone.0000389.g006
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The function and origin of autoantibodies targeting brain
protein observed in sera of CM patients is yet to be determined. In
addition to the autoantibodies to a2II spectrin, others reacting
with CNS voltage-gated calcium channels were also found to be
associated with an increased risk of developing severe disease in
Kenyan children [3]. The production of autoantibodies to brain
proteins could be considered as a signature of clinical severity in
malaria.
Self-reactive antibodies to brain produced during P. falciparum
malaria may have distinct origins including polyclonal B-cell
activation or the activation of specific B-cell clones. Parasite
antigens and/or parasite-derived mitogens can lead to the non-
specific polyclonal activation of B lymphocytes [5,38], and in
particular to stimulation of the physiological B-cell repertoire,
which has a natural capacity to react to various self- and/or
environmental antigens [39]. This natural self-reactive antibody
repertoire is acquired in early life and is much conserved [39–41].
However, if the self-reactive anti-brain protein antibodies detected
in our patients were essentially due to a non-specific polyclonal B-
cell activation, we would not expect any significant difference in
the proportion of self-reactive antibodies or in the frequency of
individuals producing these antibodies, between the different
symptomatic P. falciparum malaria patient cohorts. It is noteworthy
that our results showed such differences, thus suggesting that the
induction of a specific set of brain self-reactive IgG molecules was
due to the activation of a selected repertoire. Several observations
are consistent with this: 1) a single band was associated with strong
anti-brain reactivity in CM patients, particularly those with low
IgG concentrations, 2) high anti-brain reactivity was essentially
observed in the adjusted assay, in which the effects of both age and
IgG concentration were reduced, and 3) IgG concentrations were
not correlated with anti-brain reactivity or parasitemia. Nonethe-
less, the two pathways of B-cell activation, mitogenic and antigen-
specific, are not mutually exclusive in the malaria infection.
The hypothesis of a role played by autoantibodies to brain
proteins in CM pathophysiology is in agreement with previous
observations made for numerous autoimmune diseases involving
the brain [42–46]. For example, a role for self-reactive antibodies
has been implicated in the brain damage and severe pathology
observed in experimental autoimmune encephalomyelitis (EAE),
a model for multiple sclerosis [46]. Moreover, it has been shown
that in Rasmussen’s encephalitis, a childhood autoimmune
disease, the access of IgG to glutamate receptor (GluR3) B-cell
epitopes in the central nervous system triggers complement-
mediated neuronal damage and contributes to the pathogenesis
[45]. In neuropsychiatric systemic lupus erythematous, antibodies
to microtubule-associated protein 2 (MAP-2) and to cardiolipin
were also associated with the pathology [43,44]. Interestingly, the
serum of these patients contains auto-antibodies to the NMDA
receptors [42], and these elicit cognitive impairment in mice that
received lipopolysaccharide to compromise the blood brain barrier
integrity [42]. Generally speaking, a role of viral or bacterial
infections has been suggested in the development of autoimmune
diseases [47–50]. For example, an autoimmune process associated
with brain damage and dementia has been observed in HIV
infected patients [51].
An organized core autoimmune repertoire within the immune
system has been termed the immunological homunculus [52].
According to this concept, high levels of a2II spectrin auto-
antibodies would not be caused by the direct antigenic stimulation
of anti-brain a2II spectrin lymphocytes clones, but rather the
disease manifestation (CM) would be a consequence of a P.
falciparum-induced defect or weakening of the natural regulation of
homunculus autoreactivity [53,54]. Alternatively, the inflamma-
Figure 7. Total reactivity to brain proteins and intensity of IgG
reacting to band-0 as a function of plasma TNFa levels in children
older than 1 year. A. Positive correlation between PCA factor 1 and
TNFa concentrations in the CM group, indicated by dashed regression
line. B. Positive correlation between unadjusted reactivity to band 0 and
TNFa levels. C. High band-0 reactivity was observed most frequently in
CM patients with TNFa levels above 100 pg/mL (indicated as high-TNFa
in a separate group on the right). Horizontal bars indicate medians.
Only children over the age of 1 year are shown.
doi:10.1371/journal.pone.0000389.g007
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tion associated with the sites of parasitized and non-parasitized red
blood cells sequestration and brain ischemia could lead to
neuronal damage and exposure of self-antigens which in turn will
elicit a self-reactive antibody response, thus amplifying brain
damage [18–22]. Observations of this process in various
pathological conditions such as brain contusion [55] and hypoxia
[56] support this hypothesis. Therefore, the presence of self-
reactive antibodies to a-II spectrin might be consequent to parasite
exposure, and their levels might simply parallel the degree of
neuronal damage. In this context, these antibodies would not be
implicated in the pathogenic process, but rather behave as
a marker of severity. In both hypothesis, and by analogy to
tissue-specific autoimmune diseases, the presence of antibodies
recognizing self antigens may amplify any neuronal damage
resulting from the inflammation initiated by parasite sequestration
in the brain [57]. In this case, these antibodies would exacerbate
the pathogenic process. Clearly, the role of self-reactive antibodies
in the pathogenesis of CM and other severe manifestations of
malaria should be investigated further in different cohorts from
endemic regions. Furthermore, it will be of interest to determine
whether cytophilic antibodies to a-II spectrin play a role in
neuropathogenesis since the presence of cytophilic antibodies in
the serum of rats immunized with rat myelin basic protein (MBP)
has been reported in EAE [58].
Another mechanism which may explain the genesis of an
autoimmune B cell repertoire to brain antigens linked to the
neuropathology of malaria could be Fas-derived apoptosis during
the course of the fatal disease, as it has been suggested for
experimental cerebral malaria in macaques and mice [59, 60].
This notion is supported by the observation that CM incidence
was reduced in Fas/Fas-L-deficient mice [61]. In this context,
a significant increase of plasma levels of sFas-L with disease
severity was noted previously in malaria patients [62], as well as in
a study we undertook in the same cohorts of patients (unpublished
results). Neuronal cell death by apoptosis during CM could then
be a potential source of autoantigens that may lead to stimulation
of the autoimmune responses [63].
In conclusion, the observation that children exposed to P.
falciparum malaria have antibodies to brain antigen in their plasma,
may be the consequence of a cumulation number of sub-clinical
brain damage resulting from previous episodes of severe non-
cerebral malaria. Irreversible damage due to acute and chronic
malaria episodes has been recorded in experimental infections of
mice with Plasmodium [64]. Repeated malaria episodes would lead
to higher levels of anti-brain antibodies of increasing complexity in
terms of antigen repertoire specificity. The risk of developing
cerebral malaria would then increase with the presence and level
of these antibodies. An initial parasite-mediated lesion in the brain
causing neuronal damage and leakage in the blood brain barrier
will allow serum autoantibodies to bind to their cognate brain
antigens leading to complement activation and further inflamma-
tion, oedema, and brain damage. Clearly, it would be interesting
to determine the prevalence and levels of anti-a-II spectrin
autoantibodies in endemic residents. If two cohorts distinguished
by significantly different levels of these antibodies could be
constituted, then it will be possible to conduct a prospective study
that could allow to determine whether high anti-aII spectrin
autoantibody levels predispose an individual to develop CM.
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